GENOTECHGENOTECHGENOTECH

GENOTECH

No trades
See on Supercharts
Market capitalization
‪7.93 B‬KRW
‪−262.92 M‬KRW
‪2.75 B‬KRW
Beta (1Y)
−0.11
Employees (FY)
28
Change (1Y)
−4 −12.50%
Revenue / Employee (1Y)
‪98.23 M‬KRW
Net income / Employee (1Y)
‪−9.39 M‬KRW

About GENOTECH


CEO
Jae-Jong Kim
Headquarters
Daejeon
Founded
1997
ISIN
KR7066830001
FIGI
BBG00DB42551
GenoTech Corp. engages in the production, sales of biotechnology related products and in provision of technical and academic services. It operates through the following business areas: Bio, Gene Synthesis, and Genetic Analysis. The Bio business area offers bio-technology based products and services for improvement of human health, disease prevention, diagnosis and treatment. The Gene Synthesis business area provides products used for biotechnology research and development such as oligonucleotides, enzymes, cloning technology kits and others. The Genetic Analysis business area offers genome analytic and genome sequencing services. The company was founded on July 8, 1997 and is headquartered in Daejeon, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 066830 is 1,200 KRW — it has decreased by −14.22% in the past 24 hours. Watch GENOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOTECH stocks are traded under the ticker 066830.
066830 stock has fallen by −9.64% compared to the previous week, the month change is a −13.98% fall, over the last year GENOTECH has showed a −29.41% decrease.
066830 reached its all-time high on Jul 27, 2016 with the price of 11,650 KRW, and its all-time low was 940 KRW and was reached on Mar 23, 2020. View more price dynamics on 066830 chart.
See other stocks reaching their highest and lowest prices.
066830 stock is 16.58% volatile and has beta coefficient of −0.11. Track GENOTECH stock price on the chart and check out the list of the most volatile stocks — is GENOTECH there?
Today GENOTECH has the market capitalization of ‪6.80 B‬, it has increased by 5.35% over the last week.
Yes, you can track GENOTECH financials in yearly and quarterly reports right on TradingView.
No, 066830 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 28.00 employees. See our rating of the largest employees — is GENOTECH on this list?
Like other stocks, 066830 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOTECH technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOTECH stock shows the strong sell signal. See more of GENOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.